Program in Oncology for Tribal Health Systems.

Conditions

• Patient Outcomes

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• C3PO — OTHER
  Participants assigned to C3PO will receive usual navigation services with a Native American Navigator (NAN) at the SCC but will begin having their clinical care and social needs discussed during monthly collaborative care meetings. For the Open Pilot, this will include all participants (no randomization or usual care group). The collaborative care coordinator will meet with the participant virtually or in-person before and after collaborative care meetings as they are available and as needs arise.

Study Details

This clinical trial aims to develop and implement more navigation assistance programs tailored specifically for Native American cancer patients, addressing the current lack of available support. The goal is to improve communication barriers within the healthcare system by fostering a collaborative approach between the Stephenson Cancer Center (SCC) and tribally operated healthcare systems (ITU). Through this partnership, the trial seeks to enhance patient outcomes by providing culturally sensitive, coordinated care.

Key Dates

Start date

Feb 11, 2026

Status verified

Jun 2026

Primary completion

Mar 31, 2030

Completion

Mar 31, 2031

Study Design

Enrollment

187 participants (estimated)

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Arms

• Experimental: Open Pilot Study
  During the open pilot study, which will take place over a 3-month period, up to 15 patients will be enrolled to receive the C3PO intervention. At the conclusion of this period, exit interviews will be conducted to gather feedback on the implementation of the intervention. The primary objective of this phase is to assess the strengths and weaknesses of the intervention in order to inform potential improvements before advancing to the next phase of the study
• Experimental: C3PO Intervention
  In Phase II of the study, patients will be randomized 1:1 by site and cancer type to either the C3PO intervention group or the usual care group. Those assigned to the C3PO arm will receive navigation services at SCC, along side collaborative care meetings (C3PO). These meetings, held without the patient present, will focus on discussing the patient's overall needs, such as potential adverse effects of cancer treatment, the impact of co-morbid conditions, etc,.
• Active Comparator: Usual Care
  Patients randomized to the usual care group will receive navigation services only and will not participate in the C3PO intervention during the initial 6 months. However, after this 6-month period, they will become eligible to receive the C3PO intervention, following the same process as the initial intervention group.

Primary Outcome Measure

Perceptions of Cancer Care Coordination Needs [ Time Frame: 1 year ]

Central Contacts

• Amanda Janitz, Ph.D.
  405-271-2229
  [email protected]

Locations (1)

Find similar trials in Oklahoma City, OK

Related Studies

• The PRIME Study: A Randomized, Controlled, Prospective Study
  PHASE4 · Recruiting · Vance Thompson Vision - MT · Bozeman, Montana